These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24242074)

  • 21. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10 effects in neurodegenerative disease.
    Spindler M; Beal MF; Henchcliffe C
    Neuropsychiatr Dis Treat; 2009; 5():597-610. PubMed ID: 19966907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
    Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF
    J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
    Beal MF
    Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M
    Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Bakhshayeshkaram M; Lankarani KB; Mirhosseini N; Tabrizi R; Akbari M; Dabbaghmanesh MH; Asemi Z
    Curr Pharm Des; 2018; 24(31):3710-3723. PubMed ID: 30417782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondria, NO and neurodegeneration.
    Beal MF
    Biochem Soc Symp; 1999; 66():43-54. PubMed ID: 10989656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Juanak N
    J Clin Pharm Ther; 2015 Aug; 40(4):413-8. PubMed ID: 25913756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial approaches for neuroprotection.
    Chaturvedi RK; Beal MF
    Ann N Y Acad Sci; 2008 Dec; 1147():395-412. PubMed ID: 19076459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency.
    García-Corzo L; Luna-Sánchez M; Doerrier C; Ortiz F; Escames G; Acuña-Castroviejo D; López LC
    Biochim Biophys Acta; 2014 Jul; 1842(7):893-901. PubMed ID: 24576561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Coenzyme Q10 Supplementation on Lipid Profiles Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Sharifi N; Tabrizi R; Moosazadeh M; Mirhosseini N; Lankarani KB; Akbari M; Chamani M; Kolahdooz F; Asemi Z
    Curr Pharm Des; 2018; 24(23):2729-2742. PubMed ID: 29623830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Parohan M; Sarraf P; Javanbakht MH; Ranji-Burachaloo S; Djalali M
    Nutr Neurosci; 2020 Nov; 23(11):868-875. PubMed ID: 30727862
    [No Abstract]   [Full Text] [Related]  

  • 38. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome.
    Llewellyn KJ; Nalbandian A; Gomez A; Wei D; Walker N; Kimonis VE
    Neurobiol Dis; 2015 Apr; 76():77-86. PubMed ID: 25684537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of trimetazidine and coenzyme Q10 for the treatment of acute viral myocarditis: a systematic review and meta-analysis.
    Zeng M; Chen Z; Zhang Y; Pang Y
    J Infect Dev Ctries; 2024 May; 18(5):658-665. PubMed ID: 38865387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
    Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
    Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.